Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-24 @ 6:50 PM
NCT ID:
NCT04486157
Brief Summary:
The main purpose of this study is to demonstrate the bioequivalence between IN-A012 and Akynzeo capsules by pharmacokinetic(PK) evaluation
Detailed Description:
\[Pharmacokinetics Assessment\]
* Primary Parameter
\- AUC0-t
* Secondary Parameters - Cmax, tmax
\[Safety Assessment\]
\- Adverse events, vital signs, physical examination, 12-lead ECGs, and clinical laboratory tests
Study:
NCT04486157
Study Brief:
Protocol Section:
NCT04486157